A review discussing fluciclovine
A review discussing fluciclovine
About this item
Full title
Author / Creator
Publisher
Future Medicine Ltd
Journal title
Language
English
Formats
Publication information
Publisher
Future Medicine Ltd
Subjects
More information
Scope and Contents
Contents
A significant number of patients radically treated for prostate cancer (PCa) will develop prostate-specific antigen recurrence (27-53%). Localizing the anatomical site of relapse is critical, in order to achieve the optimal treatment management. To date the diagnostic accuracy of standard imaging is low. Several desirable features have been identif...
Alternative Titles
Full title
A review discussing fluciclovine
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_futurescience_futuremedicine_10_2217_fon_2017_0446
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_futurescience_futuremedicine_10_2217_fon_2017_0446
Other Identifiers
ISSN
1479-6694
E-ISSN
1744-8301
DOI
10.2217/fon-2017-0446
